Leap Therapeutics, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
Winklevoss Treasury Investments assigned common warrants for 5.6 million shares of Cypherpunk Technologies to Who Datz LLC for no consideration.
Winklevoss Capital entities have acquired a 19.9% beneficial ownership stake in Leap Therapeutics, Inc. through a private placement, gaining significant board representation.